Skip to main content

Table 2 TA-TAVI infection vs no-infection demographic and operative variables

From: Surgical site infections following transcatheter apical aortic valve implantation: incidence and management

 

No infection

Infection

P

 

(n=149)

(n=5)

 

Age

78.7±7.9

75±6.3

0.3079

Men (%)

43.0 (64/149)

20 (1/5)

0.3067

Weight (kg)

67.1±14.9

78.2±10

0.0996

BMI

26.7±5.3

31.4±3.1

0.0504

HBP (%)

82.6 (123/149)

100 (5/5)

0.3056

DM (%)

34.2 (51/149)

20 (1/5)

0.5081

Cr.clearance (median)

39.7±16.5 (37.5)

44.1±19.9 (31.8)

0.5580

DLP (%)

89.9 (134/149)

100 (5/5)

0.4552

PVD (%)

45.6 (68/149)

40 (2/5)

0.8033

COPD (%)

26.2 (39/149)

40 (2/5)

0.4915

Stroke (%)

3.4 (5/149)

0 (0/5)

0.6771

GI comp (%)

6.7 (10/149)

20 (1/5)

0.2564

ARF (%)

18.1 (27/149)

20 (1/5)

0.9147

Septicaemia (%)

0

0

-

Bronchitis/Pneumonia (%)

21.5 (32/149)

40 (2/5)

0.3260

UTI (%)

18.1 (27/149)

20 (1/5)

0.9147

Death (%)

12.8 (19/149)

0

0.3938